Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Case Report
Treatment of Lyme Diseasewith Human Embryonic Stem Cells: A Case Series
Geeta Shroff*
Director, NutechMediworld, New Delhi, India
- *Corresponding Author:
- GeetaShroff
NutechMediworld, H-8 Green Park Extension
New Delhi-110016 India
Tel: +91 11 26565548
Fax: +91 11 46057841
E-mail: geetashroff@hotmail.com
Received January 20, 2015; Accepted February 28, 2015; Published March 3, 2015
Citation: Shroff G (2015) Treatment of Lyme Diseasewith Human Embryonic Stem Cells: A Case Series. J Neuroinfect Dis 6:167. doi:
Copyright: ©2015Shroff G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Lyme Disease (LD) is a tick-borne disease caused by Borreliaburgdorferi (Bb) and transmitted in humans by Ixodesscapularis. LD can affect any organ of the body. The present study evaluated the efficacy and safety of human embryonic stem cell (hESC) therapy for the treatment of LD.
Methods: Patients included in the present study had experienced symptoms of LD to varying degree of severities and intensities. The study consisted of treatment phases separated by gap phases in-between.
Results: Improvement in symptoms was observed receiving hESC therapy. hESC therapy showed considerable improvement in the condition of the patients who were unable to walk straight or maintain balance while sitting and standing. These patients had regained their balance and had started to perform their regular activities with less effort after receiving hESC therapy. In addition, patients showed improvement in blurred vision, tremors, had higher energy levels, improved stamina, appetite, decreased numbness in the upper limb, decreased stiffness, regained balance, and had no slurring of speech after receiving hESC therapy.
Conclusion: In conclusion, hESC therapy has shown significant improvement in patients with LD. Improvement in patients was observed without any adverse events.
